AGIO:NASDAQ
Agios Pharmaceuticals Inc
$29.68
arrow_downward
-0.70%(-0.21) 1D
$29.68
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 18, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$29.57
High
$30.48
Low
$29.22
Mkt. cap
1.78B
Avg. vol.
1.21M
Volume
0.00
52-wk high
$44.07
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
Open
$29.57
High
$30.48
Low
$29.22
Mkt. cap
1.78B
Avg. vol.
1.21M
Volume
0.00
52-wk high
$44.07
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
News stories
From web sources and news partners
TradingView
·
1 hour ago
Stock Market Today: Dow, S&P 500 Futures Rise as Wall Street Awaits Anthropic's Listing— PANW, NTES, SLS in Focus
BigGo Finance
·
1 hour ago
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
Yahoo Finance
·
1 hour ago
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
Business Insider
·
1 hour ago
Why Morgan Stanley Says the S&P 500 Is Poised to Jump 18%
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc